Cargando…
4-Bromo-2-(5-bromothiophen-2-yl)-1-[(5-bromothiophen-2-yl)methyl]-5,6-dimethyl-1H-benzimidazole
The title compound, C(18)H(13)Br(3)N(2)S(2), was obtained via the reaction of N-bromosuccinamide with 5,6-dimethyl-2-(thiophen-2-yl)-1-[(thiophen-2-yl)methyl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromothiophen-2-yl substituent with a refined major:minor occupanc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998606/ https://www.ncbi.nlm.nih.gov/pubmed/24826179 http://dx.doi.org/10.1107/S160053681400628X |
_version_ | 1782313398239756288 |
---|---|
author | Geiger, H. Cristina Donohoe, James S. Geiger, David K. |
author_facet | Geiger, H. Cristina Donohoe, James S. Geiger, David K. |
author_sort | Geiger, H. Cristina |
collection | PubMed |
description | The title compound, C(18)H(13)Br(3)N(2)S(2), was obtained via the reaction of N-bromosuccinamide with 5,6-dimethyl-2-(thiophen-2-yl)-1-[(thiophen-2-yl)methyl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromothiophen-2-yl substituent with a refined major:minor occupancy ratio of 0.876 (7):0.124 (7). The 5-bromothiophen-2-yl mean plane is canted to the benzimidazole plane by 20.0 (4) and 21 (4)° in the major and minor components, respectively. In the crystal, weak C—H⋯N interactions link the molecules into infinite C(7) chains along the 2(1) axes. |
format | Online Article Text |
id | pubmed-3998606 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-39986062014-05-13 4-Bromo-2-(5-bromothiophen-2-yl)-1-[(5-bromothiophen-2-yl)methyl]-5,6-dimethyl-1H-benzimidazole Geiger, H. Cristina Donohoe, James S. Geiger, David K. Acta Crystallogr Sect E Struct Rep Online Organic Papers The title compound, C(18)H(13)Br(3)N(2)S(2), was obtained via the reaction of N-bromosuccinamide with 5,6-dimethyl-2-(thiophen-2-yl)-1-[(thiophen-2-yl)methyl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromothiophen-2-yl substituent with a refined major:minor occupancy ratio of 0.876 (7):0.124 (7). The 5-bromothiophen-2-yl mean plane is canted to the benzimidazole plane by 20.0 (4) and 21 (4)° in the major and minor components, respectively. In the crystal, weak C—H⋯N interactions link the molecules into infinite C(7) chains along the 2(1) axes. International Union of Crystallography 2014-03-26 /pmc/articles/PMC3998606/ /pubmed/24826179 http://dx.doi.org/10.1107/S160053681400628X Text en © Geiger et al. 2014 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Organic Papers Geiger, H. Cristina Donohoe, James S. Geiger, David K. 4-Bromo-2-(5-bromothiophen-2-yl)-1-[(5-bromothiophen-2-yl)methyl]-5,6-dimethyl-1H-benzimidazole |
title | 4-Bromo-2-(5-bromothiophen-2-yl)-1-[(5-bromothiophen-2-yl)methyl]-5,6-dimethyl-1H-benzimidazole |
title_full | 4-Bromo-2-(5-bromothiophen-2-yl)-1-[(5-bromothiophen-2-yl)methyl]-5,6-dimethyl-1H-benzimidazole |
title_fullStr | 4-Bromo-2-(5-bromothiophen-2-yl)-1-[(5-bromothiophen-2-yl)methyl]-5,6-dimethyl-1H-benzimidazole |
title_full_unstemmed | 4-Bromo-2-(5-bromothiophen-2-yl)-1-[(5-bromothiophen-2-yl)methyl]-5,6-dimethyl-1H-benzimidazole |
title_short | 4-Bromo-2-(5-bromothiophen-2-yl)-1-[(5-bromothiophen-2-yl)methyl]-5,6-dimethyl-1H-benzimidazole |
title_sort | 4-bromo-2-(5-bromothiophen-2-yl)-1-[(5-bromothiophen-2-yl)methyl]-5,6-dimethyl-1h-benzimidazole |
topic | Organic Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998606/ https://www.ncbi.nlm.nih.gov/pubmed/24826179 http://dx.doi.org/10.1107/S160053681400628X |
work_keys_str_mv | AT geigerhcristina 4bromo25bromothiophen2yl15bromothiophen2ylmethyl56dimethyl1hbenzimidazole AT donohoejamess 4bromo25bromothiophen2yl15bromothiophen2ylmethyl56dimethyl1hbenzimidazole AT geigerdavidk 4bromo25bromothiophen2yl15bromothiophen2ylmethyl56dimethyl1hbenzimidazole |